Exploring Nasal Drop Therapy With Small Extracellular Vesicles for ALS

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Amyotrophic Lateral Sclerosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Xuanwu Hospital ,Capital Medical University, Beijing, Beijing Municipality, China
Contact: Study coordinator (Gaoting Ma, MD) · demo_doctor@163.com · 01083198082

Study leads

Junwei Hao, MD; PhD
Principal Investigator
Xuanwu Hospital, Beijing

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Dazucorilant in Patients With Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis

Abroad (travel likely)RecruitingPHASE2

Phoenix, United States · San Francisco, United States

Study of COYA 302 for the Treatment of ALS

Amyotrophic Lateral Sclerosis (ALS)

Abroad (travel likely)RecruitingPHASE2

Phoenix, United States · Los Angeles, United States

Effects of Probiotics in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia Spectrum Disorder (ALS-FTDSD) Patients

ALSFTD · ALS (Amyotrophic Lateral Sclerosis) · Frontal Temporal Dementia (FTD)

Abroad (travel likely)Recruiting

Fredericton, Canada · Montreal, Canada

A Study of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis

ALS (Amyotrophic Lateral Sclerosis)

Abroad (travel likely)RecruitingPHASE1

Leuven, Belgium · Calgary, Canada